Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease.

Cichoż-Lach H, Celiński K, Prozorow-Król B, Swatek J, Słomka M, Lach T.

Med Sci Monit. 2012 Dec;18(12):CR735-40.

2.

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.

Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077.

PMID:
20801772
3.

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).

Raszeja-Wyszomirska J, Szymanik B, Ławniczak M, Kajor M, Chwist A, Milkiewicz P, Hartleb M.

BMC Gastroenterol. 2010 Jun 28;10:67. doi: 10.1186/1471-230X-10-67.

4.

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

McPherson S, Anstee QM, Henderson E, Day CP, Burt AD.

Eur J Gastroenterol Hepatol. 2013 Jun;25(6):652-8. doi: 10.1097/MEG.0b013e32835d72cf.

PMID:
23325287
5.

Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease.

Ruffillo G, Fassio E, Alvarez E, Landeira G, Longo C, Domínguez N, Gualano G.

J Hepatol. 2011 Jan;54(1):160-3. doi: 10.1016/j.jhep.2010.06.028. Epub 2010 Aug 22.

PMID:
20934232
6.

Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population.

Pérez-Gutiérrez OZ, Hernández-Rocha C, Candia-Balboa RA, Arrese MA, Benítez C, Brizuela-Alcántara DC, Méndez-Sánchez N, Uribe M, Chávez-Tapia NC.

Ann Hepatol. 2013 May-Jun;12(3):416-24.

7.

Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease.

Demir M, Lang S, Nierhoff D, Drebber U, Hardt A, Wedemeyer I, Schulte S, Quasdorff M, Goeser T, Töx U, Steffen HM.

J Clin Gastroenterol. 2013 Sep;47(8):719-26. doi: 10.1097/MCG.0b013e3182819a89.

PMID:
23442837
8.

Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease.

Xun YH, Fan JG, Zang GQ, Liu H, Jiang YM, Xiang J, Huang Q, Shi JP.

J Dig Dis. 2012 Nov;13(11):588-95. doi: 10.1111/j.1751-2980.2012.00631.x.

PMID:
23107446
9.

NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD.

Demir M, Lang S, Schlattjan M, Drebber U, Wedemeyer I, Nierhoff D, Kaul I, Sowa J, Canbay A, Töx U, Steffen HM.

PLoS One. 2013;8(3):e58360. doi: 10.1371/journal.pone.0058360. Epub 2013 Mar 26.

10.

Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).

Verma S, Jensen D, Hart J, Mohanty SR.

Liver Int. 2013 Oct;33(9):1398-405. doi: 10.1111/liv.12226. Epub 2013 Jun 13.

PMID:
23763360
11.

The utility of the "NAFLD fibrosis score" in morbidly obese subjects with NAFLD.

Qureshi K, Clements RH, Abrams GA.

Obes Surg. 2008 Mar;18(3):264-70. doi: 10.1007/s11695-007-9295-8. Epub 2008 Jan 24.

PMID:
18214632
12.

Elevated red cell distribution width is associated with advanced fibrosis in NAFLD.

Kim HM, Kim BS, Cho YK, Kim BI, Sohn CI, Jeon WK, Kim HJ, Park DI, Park JH, Joo KJ, Kim CJ, Kim YS, Heo WJ, Choi WS.

Clin Mol Hepatol. 2013 Sep;19(3):258-65. doi: 10.3350/cmh.2013.19.3.258. Epub 2013 Sep 30.

13.

Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.

Yoneda M, Imajo K, Eguchi Y, Fujii H, Sumida Y, Hyogo H, Ono M, Suzuki Y, Kawaguchi T, Aoki N, Sata M, Kanemasa K, Kohgo Y, Saibara T, Chayama K, Itoh Y, Yoshikawa T, Anzai K, Fujimoto K, Okanoue T, Nakajima A; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).

J Gastroenterol. 2013 Sep;48(9):1051-60. doi: 10.1007/s00535-012-0704-y. Epub 2012 Nov 27.

PMID:
23184095
14.

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ; Nash Clinical Research Network.

Clin Gastroenterol Hepatol. 2009 Oct;7(10):1104-12. doi: 10.1016/j.cgh.2009.05.033. Epub 2009 Jun 10.

15.

Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.

Adams LA, George J, Bugianesi E, Rossi E, De Boer WB, van der Poorten D, Ching HL, Bulsara M, Jeffrey GP.

J Gastroenterol Hepatol. 2011 Oct;26(10):1536-43. doi: 10.1111/j.1440-1746.2011.06774.x.

PMID:
21950746
16.

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.

Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Choi PC, Kowo M, Chan AW, Merrouche W, Sung JJ, de Lédinghen V.

Hepatology. 2010 Feb;51(2):454-62. doi: 10.1002/hep.23312.

PMID:
20101745
17.

The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TM, Day CP.

Hepatology. 2007 Apr;45(4):846-54.

PMID:
17393509
18.

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.

Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).

BMC Gastroenterol. 2012 Jan 5;12:2. doi: 10.1186/1471-230X-12-2.

19.

Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation.

Kumar R, Rastogi A, Sharma MK, Bhatia V, Tyagi P, Sharma P, Garg H, Chandan Kumar KN, Bihari C, Sarin SK.

Dig Dis Sci. 2013 Jan;58(1):265-74. doi: 10.1007/s10620-012-2306-1. Epub 2012 Jul 12.

PMID:
22790906
20.

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography.

Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL.

Radiology. 2013 Aug;268(2):411-9. doi: 10.1148/radiol.13121193. Epub 2013 Apr 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk